Please login to the form below

Not currently logged in
Email:
Password:

Prosonix

This page shows the latest Prosonix news and features for those working in and with pharma, biotech and healthcare.

Circassia slumps as cat allergy vaccine fails late-stage trial

Circassia slumps as cat allergy vaccine fails late-stage trial

drugs and novel combinations gained through its acquisitions of Aerocrine and Prosonix last year.

Latest news

  • Allergy specialist Circassia buys asthma firms Allergy specialist Circassia buys asthma firms

    Circassia will pay £139m ($219m) for Aerocrine and up to £100m for Prosonix. ... fit. . “Prosonix has near-term products that help us create an allergy-asthma specialist pharmaceutical company.”.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    155. Prosonix/Circassia. Corporate acquisition. Portfolio of generic respiratory products includingfluticasone. 152.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics